rwj 22108 has been researched along with verapamil in 1 studies
Studies (rwj 22108) | Trials (rwj 22108) | Recent Studies (post-2010) (rwj 22108) | Studies (verapamil) | Trials (verapamil) | Recent Studies (post-2010) (verapamil) |
---|---|---|---|---|---|
5 | 0 | 0 | 17,621 | 1,527 | 2,067 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Croxton, TL; Hirshman, CA; Namiki, A; Yamakage, M | 1 |
1 other study(ies) available for rwj 22108 and verapamil
Article | Year |
---|---|
Inhibition of voltage-dependent Ca2+ channels of porcine tracheal smooth muscle by the novel Ca2+ channel antagonist RWJ-22108.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; In Vitro Techniques; Ion Channel Gating; Muscle, Smooth; Nicardipine; Patch-Clamp Techniques; Pyridines; Swine; Trachea; Verapamil | 1997 |